Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry.
about
Genome-wide association meta-analysis for total serum bilirubin levelsThe Regulation of Steroid Action by Sulfation and DesulfationPlasma membrane transporters in modern liver pharmacologyRole of Organic Anion-Transporting Polypeptides (OATPs) in Cancer TherapyOATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamiliesTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Blood brain barrier: a challenge for effectual therapy of brain tumorsLocalization and functional characterization of the rat Oatp4c1 transporter in an in vitro cell system and rat tissuesFunctional expression of the 11 human Organic Anion Transporting Polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate.Drug uptake systems in liver and kidney: a historic perspectiveXenobiotic, bile acid, and cholesterol transporters: function and regulation.The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.Cyanobacterial Toxins of the Laurentian Great Lakes, Their Toxicological Effects, and Numerical Limits in Drinking WaterCentral neurotoxicity in cancer chemotherapy: pharmacogenetic insights.Environmental and genetic factors affecting transport of imatinib by OATP1A2Bile formation and secretion.Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.The SLCO (former SLC21) superfamily of transporters.The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.N-Glycosylation dictates proper processing of organic anion transporting polypeptide 1B1.Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.Impact of OATP transporters on pharmacokinetics.Molecular cloning and functional characterization of a rainbow trout liver Oatp.Interactions of green tea catechins with organic anion-transporting polypeptides.PDZK1 and NHERF1 regulate the function of human organic anion transporting polypeptide 1A2 (OATP1A2) by modulating its subcellular trafficking and stability.Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cellsOrganic anion transporting polypeptides in the hepatic uptake of PBDE congeners in miceFunctional characterization of liver enhancers that regulate drug-associated transporters.The expression and function of organic anion transporting polypeptides in normal tissues and in cancerDrug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsTransport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.Deregulation of ion channel and transporter encoding genes in pediatric gliomasDeterminants of post-prandial plasma bile acid kinetics in human volunteers.Transport systems for opioid peptides in mammalian tissues.Methods to evaluate biliary excretion of drugs in humans: an updated review.Apple juice greatly reduces systemic exposure to atenololMembrane transporter proteins: a challenge for CNS drug development.Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms
P2860
Q24658179-6BA48620-5FF7-4232-9391-C4E0921482C3Q26799364-FF8035C6-8BDD-4196-9C63-A0842D5E30CEQ26829263-FC71E266-916D-44D3-B576-D2BF0EC7F647Q26829894-3F8281DE-3BD3-4161-946B-0677A2A796A4Q27001267-FB6857F8-BF5B-412A-9F6F-AD6722D61C18Q27690256-01672228-8760-4CD8-870F-09256050713CQ28081947-59F8317B-50D1-400A-B79E-9190BD28E84AQ28480934-D4DFC79F-191C-4A06-95B7-77C273907281Q30367871-08EA4CA7-B5DA-4A3C-95AD-B39E623E1882Q33641993-B307BF13-EF79-4F90-AF81-B0B2E1EFD7E7Q33714593-387DD52E-0A80-4300-B073-2B00DBA34E81Q33809605-801AC9C4-03BD-4C2A-BE87-9C636F20472BQ33833344-5B1C4BDF-10DC-44AB-B633-F70F9ACC84F4Q33857581-DFDF190E-64A9-4FAC-B3E6-DAC3A711DE03Q33878471-75A0FF6E-9EAB-4110-97D5-5D3B0DF5839AQ33881922-676C10EA-8B81-4B6B-AB78-8BE858D182DBQ34299422-3A6EF9F7-72B8-4107-B5B8-6D033125DDCEQ34333710-A5F8C296-EC3C-4E4B-B6E3-2EDCD901374BQ34468094-2483B16B-B4B8-472D-8F82-70CAAC0FC332Q34534121-98A91A87-13A3-4682-8BA9-A68A53D39B5BQ34603829-5E00FE03-E791-456D-BEC6-CA9C5228087BQ34612244-852C852B-CA3C-4345-8B5D-BC7F4EBEA147Q34622748-C122622B-B8D1-43D3-9B59-FD22C6CDC75BQ34856952-A643DDB9-DC3C-4812-B028-22BCA8F2A8E7Q35146960-F5026FE6-3636-4ACA-9703-3CE0CDA65BF2Q35155913-D42B0138-C073-4AED-AAAA-E6EEA39F39FAQ35484400-2E434BDC-F143-4379-BDED-F2DAB3E7B804Q35563315-7593DE25-94AA-4E57-968A-2D9618FBCC53Q35583006-083D3F93-0B28-4A7E-906B-426758965782Q35670179-0D244CA6-450C-4EF1-999F-58732D0721D3Q35795744-C3ED3F9B-34F8-412C-ADD3-6E09EE93FB70Q35969947-F87B818F-E1F0-4A7A-99D5-F7629905B149Q35996276-5C49A3CA-37DF-419B-862C-C7D064F31262Q36414100-97038F9F-786A-41AD-9B0B-80A3D0A35596Q36440370-5A02088C-3D87-400C-B935-D338EE86A1BCQ36495774-13A2A908-68B8-45DD-BC44-F91456B2E239Q36562479-8B9768DE-F202-4AE6-AF2A-44689D094F50Q36659167-DD75CBEA-8AA4-4ADE-9F77-3DC6629DF41AQ36795136-6B519579-B555-44FF-BAF6-87CE1407BDA1Q36877910-B7176870-ECAB-4FBA-92AA-5F2D162EBFFA
P2860
Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Polymorphisms in human organic ...... ral nervous system drug entry.
@ast
Polymorphisms in human organic ...... ral nervous system drug entry.
@en
Polymorphisms in human organic anion-transporting polypeptide 1A2
@nl
type
label
Polymorphisms in human organic ...... ral nervous system drug entry.
@ast
Polymorphisms in human organic ...... ral nervous system drug entry.
@en
Polymorphisms in human organic anion-transporting polypeptide 1A2
@nl
prefLabel
Polymorphisms in human organic ...... ral nervous system drug entry.
@ast
Polymorphisms in human organic ...... ral nervous system drug entry.
@en
Polymorphisms in human organic anion-transporting polypeptide 1A2
@nl
P2093
P356
P1476
Polymorphisms in human organic ...... ral nervous system drug entry.
@en
P2093
Brenda F Leake
Gilbert W Moeckel
Guillermo Gervasini
Hartmut Glaeser
L Harris Smith
Richard B Kim
Richard L Roberts
P304
P356
10.1074/JBC.M411092200
P407
P50
P577
2005-01-04T00:00:00Z